Literature DB >> 15923412

Non small cell lung cancer patients with ECOG PS2: unsolved questions and lessons from clinical trials.

V Gebbia1, D Galetta, F De Marinis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15923412     DOI： 10.1093/annonc/mdi921

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  2 in total

1.  First-line treatment of patients with advanced or metastatic squamous non-small cell lung cancer: systematic review and network meta-analysis.

Authors:  Lisa M Hess; Amy M DeLozier; Fanni Natanegara; Xiaofei Wang; Victoria Soldatenkova; Alan Brnabic; Stephen L Able; Jacqueline Brown
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

Review 2.  A comprehensive review of nongenetic prognostic and predictive factors influencing the heterogeneity of outcomes in advanced non-small-cell lung cancer.

Authors:  Gebra Cuyún Carter; Amy M Barrett; James A Kaye; Astra M Liepa; Katherine B Winfree; William J John
Journal:  Cancer Manag Res       Date:  2014-10-23       Impact factor: 3.989
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.